Barclays
SHPH icon

Barclays’s Shuttle Pharmaceuticals SHPH Stock Holding History

Barclays’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44K Buy
+750
New +$4.91K ﹤0.01% 4852
2025
Q2 		– Hold
0
– -$1 – 5511
2025
Q1 		– Hold
0
– – – 5232
2022
Q4 		– Sell
-4
Closed -$39K – 5359
2022
Q3 		$39K Buy
+4
New +$163K ﹤0.01% 3856

Other funds holding SHPH

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

Barclays's SHPH Position: Q2 2026 in Review

Barclays opened a new position in Shuttle Pharmaceuticals (SHPH) in Q2 2026: 750 shares worth $2.44K. The stake represents ﹤0.01% of the portfolio and ranks #4852 among its holdings. This is a return to the name: Barclays previously reported a position in SHPH as recently as Q3 2022.

Barclays first reported a position in SHPH in Q3 2022 and has held it in 2 quarters since. The position peaked at $39K in Q3 2022. 5 funds tracked by Wall St. Rank hold SHPH as of Q2 2026.

  • Barclays held 750 shares of Shuttle Pharmaceuticals worth $2.44K as of Q2 2026.
  • Shuttle Pharmaceuticals was a new Barclays position in Q2 2026.
  • Shuttle Pharmaceuticals made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4852 holding.
  • Barclays first reported a position in Shuttle Pharmaceuticals in Q3 2022 and has held it in 2 quarters since.
  • Barclays's Shuttle Pharmaceuticals position peaked at $39K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.